Evaluation of Immunogenicity of a Commercially Available Live Attenuated Vaccine for Dogs Containing Canine Distemper Virus and Canine Parvovirus in African Wild Dog (Lycaon pictus pictus)
Evaluation of Immunogenicity of a Commercially Available Live Attenuated Vaccine for Dogs Containing Canine Distemper Virus and Canine Parvovirus in African Wild Dog (Lycaon pictus pictus)
Lotta Wahldén1, 3, Ulf Emanuelson1, Torsten Møller2 and Jonas Johansson Wensman1*
Figure 1:
Duration of antibody titres to canine distemper virus (CDV) depending on age at time of vaccination. Unfilled boxes are individuals vaccinated <120 days of age, and filled boxes are individuals vaccinated >120 days of age. Titres ≥ 1:256 are quoted as 257.
Figure 2:
Antibody titres (y-axis) to canine parvovirus (CPV) at different ages in days (x-axis).
June 2018
Vol. 5, Iss. 3, Pages 26-43
